Table 3.
Univariate analysis of baseline characteristics and laboratory indicators in patients with ACI andPCI
| Clinical features and laboratory indicators | Good prognosis in ACI (n = 387) | Poor prognosis in ACI (n = 151) | Non-parametric test (Z or X2 value) | P value | Good prognosis in PCI (n = 207) | Poor prognosis in PCI (n = 35) | Non-parametric test (Z or X2 value) | P valve |
|---|---|---|---|---|---|---|---|---|
| Age (years), M(QR) | 64 (22) | 74 (16) | − 6.964 | 0.000 | 63 (19) | 74 (15) | − 3.286 | 0.001 |
| Admission NIHSS, M(QR) | 3 (4) | 8 (8) | − 10.742 | 0.000 | 2 (3) | 6 (10) | − 5.291 | 0.000 |
| Barthel index, M(QR) | 90 (30) | 40 (50) | − 12.124 | 0.000 | 90 (30) | 50 (60) | − 5.991 | 0.000 |
| Hemoglobin (g/L), M(QR) | 141 (22) | 136 (25) | − 2.743 | 0.006 | 141 (18) | 138 (31) | − 1.466 | 0.148 |
| Triglycerides (mmol/L), M(QR) | 1.395 (1.700) | 1.190 (1.750) | − 2.260 | 0.024 | 1.390 (1.030) | 1.510 (1.250) | − 0.255 | 0.799 |
| Cholesterol (mmol/L), M(QR) | 4.490 (1.350) | 4.540 (1.885) | − 0.262 | 0.793 | 4.640 (1.410) | 4.270 (1.840) | − 1.078 | 0.281 |
| Low-density lipoprotein (mmol/L), M(QR) | 2.580 (1.098) | 2.520 (1.430) | − 0.805 | 0.421 | 2.570 (1.050) | 2.480 (1.450) | − 0.877 | 0.380 |
| High density lipoprotein (mmol/L), M(QR) | 0.745 (0.230) | 0.760 (0.305) | − 1.132 | 0.258 | 0.750 (0.270) | 0.720 (0.260) | − 0.533 | 0.594 |
| Blood sugar (mmol/L), M(QR) | 6.470 (3.205) | 7.025 (4.218) | − 2.703 | 0.007 | 6.945 (3.980) | 8.120 (4.500) | − 1.842 | 0.065 |
| Creatinine (umol/L), M(QR) | 71.000 (24.000) | 72.800 (29.700) | − 1.507 | 0.132 | 71.100 (21.600) | 77.700 (29.600) | − 2.231 | 0.026 |
| Urea nitrogen (umol/L), M(QR) | 5.300 (2.350) | 6.000 (3.125) | − 3.427 | 0.001 | 5.400 (2.075) | 6.000 (3.800) | − 2.187 | 0.029 |
| Gender, n(%) | 4.675 | 0.031 | 0.002 | 0.960 | ||||
| Female | 109 (28.2%) | 57 (37.7%) | 60 (29.0%) | 10 (28.6%) | ||||
| Male | 278 (71.8%) | 94 (62.3%) | 147 (71.0%) | 25 (71.4%) | ||||
| History | ||||||||
| Diabetes, n(%) | 4.412 | 0.036 | 7.710 | 0.005 | ||||
| No | 277 (71.6%) | 94 (62.3%) | 134 (64.7%) | 14 (40.0%) | ||||
| Yes | 110 (28.4%) | 57 (37.7%) | 73 (35.3%) | 21 (60.0%) | ||||
| Hypertension, n(%) | 1.069 | 0.301 | 3.669 | 0.055 | ||||
| No | 144 (37.2%) | 49 (32.5%) | 69 (33.3%) | 6 (17.1%) | ||||
| Yes | 243 (62.8%) | 102 (67.5%) | 138 (66.7%) | 29 (82.9%) | ||||
| Hyperlipidemia, n(%) | 0.069 | 0.792 | 0.601 | 0.438 | ||||
| No | 324 (83.7%) | 125 (82.8%) | 171 (82.6%) | 27 (77.1%) | ||||
| Yes | 63 (16.3%) | 26 (17.2%) | 36 (17.4%) | 8 (22.9%) | ||||
| Smoking, n(%) | 9.009 | 0.029 | 0.981 | 0.806 | ||||
| No smoking | 187 (48.3%) | 86 (57.0%) | 108 (52.2%) | 19 (54.3%) | ||||
| Quit smoking | 36 (9.3%) | 18 (11.9%) | 28 (13.5%) | 6 (17.1%) | ||||
| Still smoking | 160 (41.4%) | 43 (28.5%) | 68 (32.9%) | 10 (28.6%) | ||||
| Unknown | 4 (1.0%) | 4 (2.6%) | 3 (1.4%) | 0 (0.0%) | ||||
| Drinking, n(%) | 11.319 | 0.079 | 4.865 | 0.561 | ||||
| No drinking | 252 (65.1%) | 117 (77.4%) | 131 (63.3%) | 25 (71.4%) | ||||
| Drink moderately | 90 (23.2%) | 20 (13.2%) | 47 (22.7%) | 7 (20.0%) | ||||
| Moderate drinking | 23 (5.9%) | 6 (4.0%) | 9 (4.4%) | 0 (0.0%) | ||||
| Heavy drinking | 6 (1.6%) | 1 (0.7%) | 4 (1.9%) | 0 (0.0%) | ||||
| Unknown alcohol consumption | 7 (1.8%) | 1 (0.7%) | 5 (2.4%) | 0 (0.0%) | ||||
| Quit alcohol | 8 (2.1%) | 5 (3.3%) | 9 (4.3%) | 3 (8.6%) | ||||
| Unknown | 1 (0.3%) | 1 (0.7%) | 2 (1.0%) | 0 (0.0%) | ||||
| Cerebral Infarction, n(%) | 18.812 | 0.000 | 8.944 | 0.003 | ||||
| No | 284 (73.4%) | 82 (54.3%) | 166 (80.2%) | 20 (57.1%) | ||||
| Yes | 103 (26.6%) | 69 (45.7%) | 41 (19.8%) | 15 (42.9%) | ||||
| Cerebral hemorrhage, n(%) | 9.636 | 0.002 | 0.127 | 0.722 | ||||
| No | 377 (97.4%) | 138 (91.4%) | 203 (98.1%) | 34 (97.1%) | ||||
| Yes | 10% (2.6%) | 13 (8.6%) | 4 (1.9%) | 1 (2.9%) | ||||
| TIA, n(%) | 0.243 | 0.622 | 0.269 | |||||
| No | 381 (98.4%) | 147 (97.4%) | 206 (99.5%) | 34 (97.1%) | ||||
| Yes | 6 (1.6%) | 4 (2.6%) | 1 (0.5%) | 1 (2.9%) | ||||
| Heart failure, n(%) | 1.690 | 0.194 | 0.467 | |||||
| No | 384 (99.2%) | 147 (97.4%) | 204 (98.6%) | 34 (97.1%) | ||||
| Yes | 3 (0.8%) | 4 (2.6%) | 3 (1.4%) | 1 (2.9%) | ||||
| Coronary Heart Disease, n(%) | 3.894 | 0.048 | 0.011 | 0.915 | ||||
| No | 321 (82.9%) | 114 (75.5%) | 176 (85.0%) | 30 (85.7%) | ||||
| Yes | 66 (17.1%) | 37 (24.5%) | 31 (15.0%) | 5 (14.3%) | ||||
| Atrial fibrillation, n(%) | 4.366 | 0.037 | 0.252 | 0.615 | ||||
| No | 360 (93.0%) | 132 (87.4%) | 197 (95.2%) | 32 (91.4%) | ||||
| Yes | 27 (7.0%) | 19 (12.6%) | 10 (4.8%) | 3 (8.6%) | ||||
| Tumor, n(%) | 10.072 | 0.002 | 0.312 | 0.576 | ||||
| No | 380 (98.2%) | 140 (92.7%) | 200 (96.6%) | 35 (100.0%) | ||||
| Yes | 7 (1.8%) | 11 (7.3%) | 7 (3.4%) | 0 (0.0%) | ||||
| MRS at admission, n(%) | 159.495 | 0.000 | 60.548 | 0.000 | ||||
| 0 | 10 (2.6%) | 2 (1.3%) | 2 (1.0%) | 0 (0.0%) | ||||
| 1 | 94 (24.3%) | 5 (3.3%) | 76 (36.7%) | 1 (2.9%) | ||||
| 2 | 128 (33.1%) | 18 (11.9%) | 55 (26.6%) | 5 (14.3%) | ||||
| 3 | 95 (24.5%) | 27 (17.9%) | 45 (21.7%) | 7 (20.0%) | ||||
| 4 | 54 (14.0%) | 58 (38.4%) | 27 (13.0%) | 14 (40.0%) | ||||
| 5 | 6 (1.5%) | 41 (27.2%) | 2 (1.0%) | 8 (22.8%) | ||||
| Length of hospital stay, n(%) | 78.143 | 0.000 | 30.651 | 0.000 | ||||
| < 2 weeks | 257 (66.4%) | 51 (33.8%) | 125 (60.4%) | 12 (34.3%) | ||||
| ≥ 2 weeks and < 4 weeks | 123 (31.8%) | 70 (46.3%) | 75 (36.2%) | 13 (37.1%) | ||||
| ≥ 4 weeks | 7 (1.8%) | 30 (19.9%) | 7 (3.4%) | 10 (28.6%) | ||||
| TOAST type, n(%) | 33.715 | 0.000 | 8.654 | 0.034 | ||||
| Atherosclerotic stroke | 204 (52.7%) | 75 (49.7%) | 106 (51.2%) | 20 (57.1%) | ||||
| Cardiogenic embolism | 12 (3.1%) | 13 (8.6%) | 5 (2.4%) | 4 (11.4%) | ||||
| Arteriole occlusive stroke | 95 (24.6%) | 11 (7.3%) | 37 (17.9%) | 3 (8.6%) | ||||
| Uncertain cause | 76 (19.6%) | 52 (34.4%) | 59 (28.5%) | 8 (22.9%) |
Continuous variables are represented by the median (interquartile range), and categorical variables are represented by the number of cases (percentage of the two groups)